White & Case Advises Hikma Pharmaceuticals on US$500 Million Five Year Eurobond Issue
1 min read
Global law firm White & Case LLP has advised Citigroup Global Markets Limited, HSBC Bank plc, Merrill Lynch International and Mizuho International plc as joint lead managers in connection with the issuance of US$500 million 3.250% Notes due 2025 by Hikma Finance USA LLC, a member of the global Hikma Pharmaceuticals group.
"We have advised the managers on this offering by an issuer operating in an important industry," said White & Case partner Debashis Dey, who co-led the Firm's deal team. "The transaction occurred during a time of market disruption due to the impact of the global pandemic, but the resilience of both the issuer and its particular industry sector led to substantial investor appetite."
White & Case partner Melissa Butler, who co-led the Firm's deal team, said: "The seamless collaboration between our teams in London, Dubai, Cairo and Riyadh were essential to the successful completion of this transaction, further strengthening White & Case's track record advising book-runners on complex cross-border transactions."
The White & Case team that advised on the transaction was led by partners Melissa Butler (London) and Debashis Dey (Dubai & London) and included partner Megren M. Al-Shaalan (Riyadh), local partners Sherief Rashed (Cairo) and Ibrahim Bakhurji (Riyadh), counsel Xuan Jin (Dubai) and associates Michael Byrd (London) and Cherif Tabei (Cairo).
For more information, please speak to your local media contact.